Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: MDM2 promoter polymorphism and p53 codon 72 polymorphism in chronic myeloid leukemia: The association between MDM2 promoter genotype and disease susceptibility, age of onset, and blast‐free survival in chronic phase patients receiving imatinib, Molecular Carcinogenesis, July 2013, Wiley,
DOI: 10.1002/mc.22061.
You can read the full text:
Contributors
The following have contributed to this page
